Background. In vitro studies have reported that beat-to-beat variance in tachycardia cycle length and in conduction and repolarization properties can result in spontaneous termination of reentrant arrhythmias. The purpose of this study was to define the ECG patterns associated with spontaneous termination of ventricular tachycardia in humans late after myocardial infarction.
T he prognosis of patients experiencing recurrent, sustained ventricular tachycardia in the absence of a reversible cause is poor. VT indicates ventricular tachycardia.
Methods

Patients
Four categories of inducible ventricular tachycardia were studied: inducible sustained ventricular tachycardia in an antiarrhythmic drug-free state, spontaneously terminating ventricular tachycardia in an antiarrhythmic drug-free state, sustained ventricular tachycardia on antiarrhythmic therapy, and spontaneously terminating ventricular tachycardia on antiarrhythmic therapy. To describe ECG patterns of spontaneous termination of ventricular tachycardia, two groups of patients were studied. Sixteen patients (group 1) had inducible sustained ventricular tachycardia at an antiarrhythmic drug-free electrophysiological study and inducible spontaneously terminating ventricular tachycardia on a drug therapy. Eight of these patients also had sustained ventricular tachycardia on another ineffective antiarrhythmic drug therapy. Ten patients (group 2) who had only inducible spontaneously terminating ventricular tachycardia in the antiarrhythmic drug-free state served as control subjects. They were not subsequently treated with antiarrhythmic drug therapy. All patients in both groups had coronary artery disease and previous myocardial infarction (Table 1) .
Induction of Ventricular Tachycardia
The rationale of our ventricular tachycardia induction protocol has been described previously.7 Single, double, and triple extrastimuli were delivered to the right ventricular apex after 8-beat trains at cycle lengths of 600, 500, and 400 milliseconds. Thereafter, 6 -and 12-beat trains of stimuli at a cycle length of 300 milliseconds, decrementing each train by 10 milliseconds until 2:1 ventricular capture. If ventricular tachycardia was not reproducibly induced, the stimulation protocol was repeated from the right ventricular outflow tract. The end point of programmed stimulation was completion of the entire protocol or induction of sustained ventricular tachycardia. Ventricular tachycardia was defined as 5 or more consecutive ventricular beats at a cycle length of 500 milliseconds or less and was considered sustained when it persisted for at least 30 seconds or required immediate termination because of hemodynamic compromise. Spontaneously terminating ventricular tachycardia was that which persisted for at least 5 beats but which spontaneously terminated in less than 30 seconds. The longest episode of spontaneously terminating ventricular tachycardia is reported for each patient.
Electrocardiographic Measurements
Surface ECG leads I, aVF, and V, were recorded simultaneously with intracardiac electrograms from the right ventricular apex and the right ventricular outflow tract at a paper speed of 100 mm/s. ECG intervals were measured on a beat-to-beat basis during induced ventricular tachycardia. These intervals included surface QRS duration, the surface QT interval, and ventricular tachycardia cycle length. Ventricular tachycardia morphology was also evaluated on a beat-by-beat basis. For comparative purposes, each beat of spontaneously terminating tachycardia was matched to the corresponding beat during the initial portion of sustained ventricular tachycardia. For example, the last beat of a 15-beat episode of a spontaneously terminating ventricular tachycardia would be compared with the 15th beat of sustained ventricular tachycardia in that same patient.
A number of unique definitions were used to assess these ECG intervals. During ventricular tachycardia, the point of T wave offset is seldom identifiable. Accordingly, ventricular repolarization time was measured from QRS onset to the peak of the T wave (QTp). The ECG lead in which the peak (or nadir) of the T wave was sharpest was selected for serial measurements. When the peak of the T wave could not be clearly defined, no measurement was recorded. presenting with sustained ventricular tachycardia. However, these differences were not statistically significant. VT indicates ventricular tachycardia. Table 4 ). RBBB indicates right bundle branch block; LBBB, left bundle branch block; LAD, left axs deviation; RAD, right axis deviation.
proportion of patients with QTp impingement was significantly different comparing drug-free individuals with sustained vs spontaneously terminating ventricular tachycardia (Table 3 ; P<.0001; column 1 vs column 4). Table 3 illustrates the relation between transient shortening of QRS duration and spontaneous termination of ventricular tachycardia in the same patients presented in Table 3 . In 11 of the 14 patients with spontaneously terminating ventricular tachycardia on drug, there was transient shortening of QRS duration by >10 milliseconds within 3 beats of termination of the tachycardia (Table 3 , column 1). Shortening of the QRS duration never was due to a sinus capture or fusion beat. Shortening of the QRS duration occurred in association with a change in the ECG axis of the tachycardia in 3 of these 11 patients. In contrast, only 3 of these 14 patients had QRS shortening during drug-free sustained ventricular tachycardia (Table 3 , P<.007; column 1 vs column 2) (see QRS in Fig 2) . Similarly, 7 of 8 patients with drug-free spontaneously terminating ventricular tachycardia had transient QRS shortening before termination (Table 3, Table 4 ). LBBB indicates left bundle branch block; RBBB, right bundle branch block; RAD, right axis deviation; Naxis, normal axis. ble 3; P<.006; column 1 vs column 4). However, transient QRS shortening was seen in 4 of 5 patients with sustained ventricular tachycardia on drug therapy (Table 3, column 3). The proportion of patients with transient QRS shortening was not significantly different comparing individuals on effective vs ineffective antiarrhythmic drug therapy (NS; column 2 vs column 3). Table 3 shows the relation between oscillations of QTp interval and spontaneous termination of ventricular tachycardia (Fig 3) . The proportion of patients with oscillation of the QTp tended to be greater in individuals with drug-free spontaneously terminating ventricular tachycardia vs those with drug-free sustained ventricular tachycardia (Table 3 ; P=.052, column 1 vs column 4). Table 3 shows the relation between a paradoxical prolongation of QTp interval and spontaneously terminating ventricular tachycardia (Fig 4) . (Table 4) . Sustained Ventricular Tachycardia on Drug Eight of the 16 patients described above also had sustained ventricular tachycardia induced while they received another antiarrhythmic drug. The QTp interval was not measurable during ventricular tachycardia in 3 individuals. Beat-to-beat ECG intervals were measurable in the remaining 5 patients. In none of these 5 patients did the QTp interval impinge on ventricular tachycardia cycle length (Figs 2 and 4) . In all of these cases, ventricular tachycardia cycle length was markedly prolonged compared with the baseline drug-free study. There was little or no progressive beat-to-beat change in these ECG intervals.
Spontaneously Terminating Ventricular Tachycardia in the Antiarrhythmic Drug-Free State ECG intervals were measurable in 8 of 10 patients with spontaneously terminating ventricular tachycardia in the drug-free state. In the remaining two patients, the QTp interval could not be measured. All 8 patients had QTp impingement on the cycle length of tachycardia. In 6 of these 8 individuals, the QTp interval progressively increased during tachycardia and impinged on the cycle length of ventricular tachycardia before spontaneous termination (Fig 7) . Only one of these 6 
Variances in Electrocaraiographic Features
For each class of ventricular tachycardia, beat-to-beat variance of the cycle lengths, the QRS durations, and the QTp intervals occurred at the onset the tachycardia.
However, these intervals became more stable after the fifth beat of sustained tachycardias (Figs 1 through 4) . Naxis, normal axis; RAD, right axis deviation.
In contrast, marked beat-to-beat variance in the ventricular tachycardia cycle lengths, the QRS durations, and the QTp intervals were observed during episodes of spontaneously terminating ventricular tachycardia in the presence or absence of drug. As expected, mean ventricular tachycardia cycle lengths, the QRS durations, and the QTp intervals were significantly greater on antiarrhythmic drug therapy than in the antiarrhythmic drug-free state. There were no significant differences in mean ECG intervals during episodes of sustained ventricular tachycardia on ineffective drug therapy compared with spontaneously terminating ventricular tachycardia on effective drug therapy. However, the spontaneously terminating ventricular tachycardia episodes were associated with significantly greater beat-to-beat variance in the ECG intervals (Fig 8) .
Multiple linear regression was used to assess the interrelations between the statistical variance of ventricular tachycardia cycle length and the statistical variances in the QTp interval and QRS duration. The statistical variance of the different ECG intervals was computed over an identical number of beats. The beat-to-beat variance of spontaneously terminating ventricular tachycardia cycle length on drug therapy was found to be significantly related to the variance of the QTp interval (r=.67; F ratio=8.0; P=.02) but not to the variance of the QRS duration (r=.1; F ratio= -0.1; P=NS Study Limitations There are limitations to the extrapolation of information obtained from the surface ECG to potential mechanisms occurring within the reentrant circuit. It is important to emphasize that such extrapolation is currently speculative.
[. When comparing the morphologies of spontaneously terminating ventricular tachycardia on drug with the drug-free sustained ventricular tachycardia, morphologies were the same in only 5 of 14 patients. In 3 additional patients, the morphologies of some of the beats of their pleomorphic ventricular tachycardia were the same as the drug-free state; one additional patient had a spontaneously terminating ventricular tachycardia with the same bundle branch morphology but a different axis than the sustained drug-free ventricular tachycardia. In 5 patients, the bundle branch morphology of the spontaneously terminating tachycardia was completely different than the drug-free tachycardia. Therefore, the morphologies of the spontaneously terminating tachycardias are not identical to the drug-free sustained tachycardias. It is possible that the antiarrhythmic drugs suppressed induction of the original tachycardia and facilitated the induction of an unstable tachycardia with greater ECG interval variance. However, in the 5 patients with the same ECG morphologies, both drug free and on drug, QTp impingement was seen in 4, QRS shortening was seen in 4, and QTp paradox was seen in 4. This is a similar ratio, as is observed for the group as a whole.
Conclusions
This study demonstrates that the ECG feature associated with spontaneous termination of ventricular tachycardia during antiarrhythmic drug therapy consists of impingement of the QTp interval on ventricular tachycardia cycle length. In addition, greater beat-tobeat variances in ventricular tachycardia cycle lengths, surface QRS durations, and QTp intervals are associated with spontaneously terminating ventricular tachycardia. These observations may provide insights into the potential mechanisms of antiarrhythmic drug efficacy.
